Pharma-Bio Serv (PBSV) Non-Current Assets (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Non-Current Assets for 16 consecutive years, with $213126.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 56.16% year-over-year to $213126.0; the trailing twelve-month figure through Apr 2026 stood at $1.1 million (down 43.46% YoY), and the FY2025 full-year result was $266201.0, down 55.15% from the prior year.
• Non-Current Assets slipped to $213126.0 in Q2 2026 per PBSV's latest filing, from $224457.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $2.7 million in Q1 2023 and bottomed at $213126.0 in Q2 2026.
• Historically, Non-Current Assets has averaged $659288.3 across 5 years, with a median of $521787.5 in 2023.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets surged 153.05% in 2023, then tumbled 82.87% in 2024.
• Over 5 years, Non-Current Assets stood at $707243.0 in 2022, then declined by 29.17% to $500964.0 in 2023, then grew by 18.47% to $593477.0 in 2024, then tumbled by 55.15% to $266201.0 in 2025, then dropped by 19.94% to $213126.0 in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $213126.0, $224457.0, and $266201.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.